MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or HER2+ MBC

NCT03881605 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasm
Brain Metastases
Triple Negative Breast Cancer
HER2-positive Breast Cancer

Interventions

DIAGNOSTIC_TEST: MRI screening

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

[object Object]